Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.51 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.51 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.51 |
| ▸ | PLK1 | P53350 | 1/20 | 0.50 |
| ▸ | NMUR2 | Q9GZQ4 | 3/20 | 0.50 |
| ▸ | NMUR1 | Q9HB89 | 3/20 | 0.50 |
| ▸ | NPY2R | P49146 | 7/20 | 0.49 |
| ▸ | NPY4R | P50391 | 7/20 | 0.49 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.49 |
| ▸ | NPY1R | P25929 | 5/20 | 0.49 |
| ▸ | KDM1A | O60341 | 2/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | KDM5A | P29375 | 1/20 | 0.48 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.48 |
| ▸ | RAMP3 | O60896 | 3/20 | 0.48 |
| ▸ | CALCR | P30988 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8937114 | 0.89 | NPY2R (0.58) | EP300HIF1ANPY2RNPY4RNPY5R | |
| SCHEMBL8937058 | 0.89 | NPY2R (0.58) | EP300HIF1ANPY2RNPY4RNPY5R | |
| SCHEMBL29651851 | 0.88 | KEAP1 (0.53) | EP300HIF1AMAPK8MAPK9MAPK10 | |
| SCHEMBL29651846 | 0.88 | KEAP1 (0.53) | EP300HIF1AMAPK8MAPK9MAPK10 | |
| SCHEMBL30974226 | 0.87 | RAMP3 (0.50) | MAPK8MAPK9MAPK10KDM1ARAMP3 | |
| SCHEMBL30432900 | 0.87 | MAPK8 (0.59) | EP300HIF1AMAPK8MAPK9MAPK10 | |
| SCHEMBL29680199 | 0.87 | MAPK8 (0.54) | EP300HIF1AMAPK8MAPK9MAPK10 | |
| SCHEMBL30607432 | 0.87 | EP300 (0.58) | EP300HIF1AMAPK8MAPK9MAPK10 | |
| SCHEMBL38666025 | 0.86 | EP300 (0.62) | EP300HIF1AMAPK8MAPK9MAPK10 | |
| SCHEMBL29594926 | 0.85 | NTSR2 (0.57) | EP300HIF1ANMUR2NMUR1RAMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11860174-B2 | Anti-cannabidiol antibody and uses thereof | Bomi LLC (US) | 2024-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11860174-B2 | Anti-cannabidiol antibody and uses thereof | CNR2, CNR1, MAG | EP300 4422/4885HIF1A 4232/4885MAPK8 2168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.